Overview
Lobbying Costs
200,000€ - 299,999€
Financial year: Apr 2021 - Mar 2022
Lobbyists (Full time equivalent)
1 Fte (2)
Lobbyists with EP accreditation
1
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Terumo Blood and Cell Technologies
EU Transparency Register
294466410821-65 First registered on 14 Mar 2013
Goals / Remit
Terumo BCT, a global leader in blood component and cellular technologies, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction coupled with leading technologies in therapeutic apheresis and cell processing. We believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers.
As we strive to make even safer, higher-quality transfusions available to more people, we can unlock the potential of blood and cell therapies. We can help our customers bring even more treatment options to patients through advanced blood therapies. We can support researchers in developing cellular therapies that may fundamentally improve health care. Terumo BCT is guided by our customers' needs, aspirations and ongoing drive to improve efficiency and patient outcomes.
Terumo BCT
Unlocking the Po (...)Main EU files targeted
Medical Device Regulation
REACH
Blood Directives
Tissues Sirectives
Cross Border Directive
HTAAddress
Head Office
Ikaroslaan, 41
Zaventem 1930
BELGIUMEU Office
Ikaroslaan, 41
Zaventem 1930
BELGIUMWebsite
-
People
Total lobbyists declared
2
Employment time Lobbyists 50% 2 Lobbyists (Full time equivalent)
1
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
1 accreditations were / are live (in bold) for the selected state of 03 Oct 2023
Name Start date End Date Mr Nigel Talboys 11 Nov 2022 10 Nov 2023 Ms Nathalie Du Breuil 21 Feb 2017 18 Feb 2018 Mr Nigel Talboys 13 Sep 2016 13 Sep 2017 Mr Nigel Talboys 27 May 2015 22 May 2016 Ms Ruth Foster 08 May 2013 07 May 2014 Mr Nigel Talboys 26 Apr 2013 24 Apr 2014 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
MedTech Europe (EucoMed) www.medtecheurope.org/
MedPharmPlast www.medpharmplasteurope.org/
Blood Transfusion Association (BTA) https://bloodtransfusionassociation.org/Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Apr 2021 - Mar 2022
Lobbying costs for closed financial year
200,000€ - 299,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount rpp group srl 100,000€ - 199,999€ rpp group srl 100,000€ - 199,999€ Intermediaries for current year
Name rohde public policy Closed year Costs
200,000€ - 299,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Other activities
A number of projects in the healthcare policy area including
- Crossborder Healthcare
- Crossborder Procurement
- MDR Implementation
- Information to Patients
- Information to Donors
- RoHS
- E-Health
- E-Commerce / E-procurement
- HTA consultation
- Blood Directives Road Map
Meetings
Meetings
None declared